BSEKabra Drugs LtdMediumNeutral
Announced Tue, 21 Apr · 18:49 IST

Appointment of Ms. Monam Kapoor as Additional Director, Designated as Non-Executive and Indepenent Director of the Company.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.0%1-day move
₹27.16
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-8.0-8.0-7.5-8.0-8.0-8.1-7.0-10.6-14.7-19.9
Up moveDown movePending
AI summary

Kabra Drugs has appointed Ms. Monam Kapoor as an Additional Director (Non-Executive, Independent) effective April 21, 2026, for a 5-year term subject to shareholder approval. She is a BCA graduate and currently works as an authorised representative for a Hong Kong-based energy company's liaison office. She has cleared the Independent Director Proficiency Test (IICA, 2021) and already holds independent directorships at 5 other listed companies, including Plaza Wires, Wonder Electricals, Rajnish Wellness, Oscar Global, and Finelistings Technologies. The appointment was recommended by the Nomination and Remuneration Committee and Audit Committee, and she is not debarred by SEBI or any other authority from holding a directorship.

Likely market impact

This is a routine independent director appointment with no material impact expected on the stock price. It strengthens board independence, though investors may note she already serves on 5 other listed company boards, which could limit her time commitment.